DanCann Pharma A/S publishes Q4-2022 report
COPENHAGEN, Denmark, Feb. 28, 2023 /PRNewswire/ — DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) (“DanCann Pharma” or the “Company”), a Danish company powered by cannabinoids, hereby announce that t…